Sugai Tamostu, Takahashi Hiroshi, Habano Wataru, Nakamura Shin-ichi, Sato Kimihiko, Orii Seishi, Suzuki Kazuyuki
Division of Pathology, Central Clinical Laboratory, School of Medicine, Iwate Medical University, Morioka, Japan.
J Pathol. 2003 Jun;200(2):168-76. doi: 10.1002/path.1340.
DNA aneuploidy is a biological marker of the oncogenic potential of colorectal adenomas. The accumulation of genetic alterations of cancer-related genes is also essential for colorectal carcinogenesis. However, it is unclear whether there is any relationship between these genetic alterations and the DNA ploidy of colon tumour cells in the progression of colorectal adenomas and early colorectal carcinomas. Here we have studied the DNA ploidy state and genetic alterations occurring in colorectal tumours using the crypt isolation technique. Crypts isolated from a total of 106 colorectal tumors (adenoma, 93; early carcinoma, 13) were examined using a combination of flow cytometric analysis of DNA content, polymerase chain reaction-microsatellite assay, and single-strand conformation polymorphism assay for evidence of chromosomal allelic imbalance (AI; 17p; 5q; 18q) or p53 gene mutation. In addition, we examined microsatellite instability (MSI) with BAT 26 primer sets. DNA multiploidy was infrequently detected in colorectal adenomas (15.1%), in contrast to early carcinomas (46.2%). There was a significant difference in the incidence of AI of chromosome 18q between diploid adenomas and aneuploid populations of multiploid adenomas (18.1% vs 57.1%, p = 0.0043). Mutation of p53 was also found more frequently in aneuploid populations of early multiploid colorectal carcinomas than in early diploid colorectal carcinomas (66.7% vs 0%, p = 0.021). MSI was found in only 2 of 93 adenomas, with no MSI detected in early colorectal cancers. The two MSI-positive adenomas were diploid. We subdivided multiploid adenomas into two groups: those with a low or a high DNA index (DI). The incidence of genetic alterations of high-DI adenomas did not differ from those of low-DI adenomas. Allelic imbalance involving loci on chromosome 18q and mutations of p53 seems to be associated with the progression of diploidy to multiploidy in colorectal tumours. On the other hand, MSI may be associated with the development of some diploid tumours. In addition, the incidence of genetic alterations in the colorectal adenomas that we examined appears to be independent of the tumour's DNA index.
DNA非整倍体是结直肠腺瘤致癌潜能的生物学标志物。癌症相关基因遗传改变的积累对于结直肠癌发生也至关重要。然而,在结直肠腺瘤进展和早期结直肠癌过程中,这些遗传改变与结肠肿瘤细胞的DNA倍性之间是否存在关联尚不清楚。在此,我们使用隐窝分离技术研究了结直肠肿瘤中的DNA倍性状态和发生的遗传改变。对总共106个结直肠肿瘤(腺瘤93个;早期癌13个)分离出的隐窝,采用DNA含量流式细胞术分析、聚合酶链反应-微卫星分析以及单链构象多态性分析相结合的方法,以检测染色体等位基因失衡(AI;17p;5q;18q)或p53基因突变的证据。此外,我们用BAT 26引物组检测微卫星不稳定性(MSI)。与早期癌(46.2%)相比,结直肠腺瘤中很少检测到DNA多倍体(15.1%)。二倍体腺瘤与多倍体腺瘤的非整倍体群体中,染色体18q的AI发生率存在显著差异(18.1%对57.1%,p = 0.0043)。早期多倍体结直肠癌的非整倍体群体中p53突变也比早期二倍体结直肠癌更常见(66.7%对0%,p = 0.021)。93个腺瘤中仅2个检测到MSI,早期结直肠癌中未检测到MSI。两个MSI阳性腺瘤为二倍体。我们将多倍体腺瘤分为两组:DNA指数(DI)低或高的腺瘤。高DI腺瘤的遗传改变发生率与低DI腺瘤无差异。涉及染色体18q位点的等位基因失衡和p53突变似乎与结直肠肿瘤中二倍体向多倍体的进展有关。另一方面,MSI可能与一些二倍体肿瘤的发生有关。此外,我们检测的结直肠腺瘤中遗传改变的发生率似乎与肿瘤的DNA指数无关。
Dan Med Bull. 1993-11
J Pathol. 1998-10
EBioMedicine. 2015-9-7
Clin Exp Gastroenterol. 2008